Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02341430 · ClinicalTrials.gov registry record · Phase 4
A Longitudinal Prospective Outcomes Study of Laparoscopic Abdominal Wall Hernia Repair Using Symbotex™ Composite Mesh
A Phase 4 study of Grade I Ventral Hernia and Grade II Ventral Hernia, sponsored by Anne Arundel Health System Research Institute.
- Completed
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT02341430: Completed Phase 4 study of Grade I Ventral Hernia and Grade II Ventral Hernia, sponsored by Anne Arundel Health System Research Institute.
NCT02341430 is a Phase 4 study of Grade I Ventral Hernia and Grade II Ventral Hernia that has completed, run by Anne Arundel Health System Research Institute. The registered enrollment target is 50 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02341430, a Phase 4 study of Grade I Ventral Hernia and Grade II Ventral Hernia, has completed, sponsored by Anne Arundel Health System Research Institute.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is being done to test the efficacy of Symbotex™ as an effective synthetic mesh option in the repair of grade I and II ventral hernias.
Conditions Studied
Interventions
- DEVICE Symbotex™ Composite Mesh
Study Locations (1)
Maryland
- Anne Arundel Medical Center - Annapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2016-01 |
| Est. Completion | 2018-12-31 |
| Phase | Phase 4 |
What the finished NCT02341430 record still lists
NCT02341430 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (90% lower).
The record links to 2 conditions, with Grade I Ventral Hernia appearing as the primary indexed condition, and to 1 intervention - of which Symbotex™ Composite Mesh is the first listed.
NCT02341430 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT02341430 about?
NCT02341430 is a clinical study titled "A Longitudinal Prospective Outcomes Study of Laparoscopic Abdominal Wall Hernia Repair Using Symbotex™ Composite Mesh". This study is being done to test the efficacy of Symbotex™ as an effective synthetic mesh option in the repair of grade I and II ventral hernias.
What is the current status of trial NCT02341430?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2016-01. Estimated completion is 2018-12-31.
What conditions does trial NCT02341430 study?
This clinical trial studies the following conditions: Grade I Ventral Hernia, Grade II Ventral Hernia.
What interventions are being tested in trial NCT02341430?
The interventions under investigation include: Symbotex™ Composite Mesh (DEVICE).
Who is sponsoring clinical trial NCT02341430?
This trial is sponsored by Anne Arundel Health System Research Institute, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02341430 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02341430's enrollment target sits among peer trials
50 1255th of 2000 higher than 679 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia